2-({6-[5-Methyl-1-(4-methylphenyl)-1H-1,2,3-triazol-4-yl]imidazo[2,1-b]thiazol-5-yl}methylidene)hydrazinecarbothioamide dimethylformamide 0.25-solvate
The asymmetric unit of the title solvate, C17H16N8S2·0.25C3H7NO, consists of two C17H16N8S2 molecules and a dimethylformamide molecule disordered about a crystallographic inversion centre. Both triazole molecules feature an intramolecular C—H...N interaction, which generates an S(6) ring in each cas...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union of Crystallography
2018-01-01
|
Series: | IUCrData |
Subjects: | |
Online Access: | http://scripts.iucr.org/cgi-bin/paper?S2414314618000871 |
Summary: | The asymmetric unit of the title solvate, C17H16N8S2·0.25C3H7NO, consists of two C17H16N8S2 molecules and a dimethylformamide molecule disordered about a crystallographic inversion centre. Both triazole molecules feature an intramolecular C—H...N interaction, which generates an S(6) ring in each case. In the crystal, the components are linked by N—H...N and N—H...S hydrogen bonds to form [001] chains, which are cross-linked by weak C—H...O, C—H...N and C—H...S interactions. |
---|---|
ISSN: | 2414-3146 |